Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other Non-Current Assets: 2019-2024

Historic Other Non-Current Assets for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $578,000.

  • Benitec Biopharma's Other Non-Current Assets fell 75.66% to $55,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $55,000, marking a year-over-year decrease of 75.66%. This contributed to the annual value of $578,000 for FY2024, which is 54.88% down from last year.
  • Latest data reveals that Benitec Biopharma reported Other Non-Current Assets of $578,000 as of FY2024, which was down 54.88% from $1.3 million recorded in FY2023.
  • Over the past 5 years, Benitec Biopharma's Other Non-Current Assets peaked at $1.3 million during FY2023, and registered a low of $578,000 during FY2024.
  • In the last 3 years, Benitec Biopharma's Other Non-Current Assets had a median value of $876,000 in 2022 and averaged $911,667.
  • As far as peak fluctuations go, Benitec Biopharma's Other Non-Current Assets skyrocketed by 10,444.44% in 2020, and later tumbled by 54.88% in 2024.
  • Yearly analysis of 5 years shows Benitec Biopharma's Other Non-Current Assets stood at $949,000 in 2020, then climbed by 3.69% to $984,000 in 2021, then fell by 10.98% to $876,000 in 2022, then spiked by 46.23% to $1.3 million in 2023, then plummeted by 54.88% to $578,000 in 2024.